BSE Ltd 📉 — Why is the stock down ~5% today?
BSE is facing a combination of profit-booking, weaker derivatives-volume expectations and concerns around the sustainability of its recent earnings growth.
🔹 1. Derivatives volumes
BSE's explosive growth has been driven largely by Sensex/index-options activity. Recent data suggests options activity has softened, raising questions about whether the previous growth trajectory can continue.
🔹 2. Closing Auction Session (CAS)
The new closing-auction mechanism has changed trading behaviour and created uncertainty around BSE's derivatives volumes.
🔹 3. Valuation reset
BSE's stock had rallied enormously on expectations of sustained market-share gains. At elevated valuations, even a modest downgrade to volume/earnings expectations can trigger sharp corrections.
🔹 4. Broker caution
Recent broker commentary has highlighted risks from derivatives activity, regulatory changes, STT and competition.
🔹 5. Weak broader market
Today's risk-off environment is adding to the selling pressure.
My view:
A 5% fall doesn't necessarily mean BSE's fundamental story is broken. The key metric to watch is monthly derivatives turnover and BSE's market share.
If volumes stabilise → earnings growth can remain strong.
If volumes continue falling → the market may demand a lower valuation.
📌 Bottom line: Today's fall appears more like a re-rating/profit-booking + derivatives-volume concern than a sudden collapse in BSE's business.
#BSE #BSELimited #StockMarket #NSE #Sensex #Investing #IndianStockMarket
Indian govt is considering reducing import duty on gold & silver.
With Fed hike expectations rising and duty-cut uncertainty hanging over domestic prices, I feel it’s better to stay out of gold & silver for now and wait for clarity.
No need to catch a falling knife. 🥶
Gold slips below $4,500/oz 🥇📉
Before Kevin Warsh’s Jackson Hole speech, markets were pricing a 64% chance of the Fed keeping rates unchanged in September.
After his hawkish comments, rate-hike odds jumped to around 60%.
Warsh: price stability is now the Fed’s “predominant focus.”
The market is clearly taking the possibility of a hike more seriously.
Today, Gold slips below $4,500/oz as Fed Chair Kevin Warsh says price stability is now the Fed’s “predominant focus.”
With inflation still above the 2% target, markets are now pricing in higher odds of a rate hike, putting pressure on gold.
KMC Speciality Hospitals — an interesting follow-up to my earlier posts.
Management’s latest guidance is encouraging: ~591 additional beds with ₹519 Cr investment across Trichy & Bengaluru, with a clear focus on Centers of Excellence.
Recent results are promising too — Q1 FY27 revenue grew 38% YoY and PAT jumped 120% YoY.
I had added KMC to my personal portfolio around ₹100 levels.
Now the focus is on execution. 🏥📈
#KMC #Healthcare
US Natural Gas turning bullish 🔥
LNG flows rose to ~19.5 Bcf/d, up 11.6% WoW, while hotter weather could boost power demand.
Storage build came in at just 15 Bcf vs 16.22 Bcf expected, adding another bullish signal.
Production remains high at ~112.6 Bcf/d, so supply is still the main risk.
LNG demand + heat + tight storage builds = bullish setup for natural gas. 📈
Tilaknagar Industries update 📉
TI is down ~4% today around ₹552 after recently touching ~₹595.
The pullback comes after a sharp run-up, with profit booking likely playing a role.
Meanwhile, management said the company will focus on craft spirits within the high-growth super-premium & luxury segments.
8/8
My takeaway:
Don't worry too much about whether you “missed” a stock.
There will always be another opportunity.
Sometimes the better approach is to find a fundamentally similar growth story before the market fully prices it in.
For me, Shanti Gold ( CMP 247) is one such story I'm watching closely. 📊
Follow me for equity analysis, valuation-based ideas & potential multibaggers.
Shanti Gold down 4.4% today.
The fall seems to be more about the recent rights issue allotment and the additional shares hitting the market, rather than any major negative change in the business.
46.43 lakh shares were allotted at ₹215, with the company raising ~₹100 Cr.
After the recent run-up, some profit booking + fresh supply is understandable.
Added a small quantity of Vodafone Idea around ₹14.
Feels like a turnaround story is slowly taking shape. Subscriber growth is back, ARPU is improving and 5G/network expansion is finally picking up.
Still a very risky bet, but if execution goes right, the upside could be huge from these levels.
Interesting development for Kaynes Technology,
Kaynes has partnered with BOSGAME to bring its intelligent computing products to India.
Interesting to see Kaynes expanding beyond traditional EMS into the computing and IT hardware space.
13 Aug: ₹531 → 25 Aug: ₹592 📈
Good to see the market starting to recognize the potential in Tilaknagar Industries.
But for me, this is still the beginning of the story.
Imperial Blue integration + scale + improving margins = the real opportunity.
Tilaknagar Industries: Potential Multibagger Opportunity
CMP: ~₹531 (12 Aug 2026)
Tilaknagar is one stock I am looking at for the next 3–5 years.
The last quarter was a loss of around ₹15 Cr, mainly during the Imperial Blue integration and transition period.
But Q1 FY27 was much better.
• Revenue: ₹1,046 Cr
• Highest-ever quarterly revenue
• EBITDA: ₹169 Cr
• Highest-ever quarterly EBITDA
• Sales volume: 8.7 million cases
• Imperial Blue integration ~90% complete
The interesting part for me is what happens from here.
Imperial Blue has given Tilaknagar much bigger scale.
If they can grow volumes, improve margins, reduce debt and get the benefits of operating leverage, earnings can grow significantly from here.
Management is targeting 16–18% EBITDA margin by FY29.
I am not looking at Tilaknagar for the next few quarters.
I am looking at it as a 3–5 year potential multibagger.
There will be ups and downs during the integration, but if the business executes well, I think the earnings growth can be much bigger than what we see today.
For me, the thesis is simple:
More scale + premiumisation + volume growth + margin expansion + debt reduction = potential multibagger.
CMP today: ~₹531.
Let's see where the business and the stock stand after 3–5 years.
Follow me only if you are interested in finding potential multibaggers and investing in good businesses for the long term.
#Tilaknagar #TI #Stocks #Investing #Multibagger
Tilaknagar Industries: Potential Multibagger Opportunity
CMP: ~₹531 (12 Aug 2026)
Tilaknagar is one stock I am looking at for the next 3–5 years.
The last quarter was a loss of around ₹15 Cr, mainly during the Imperial Blue integration and transition period.
But Q1 FY27 was much better.
• Revenue: ₹1,046 Cr
• Highest-ever quarterly revenue
• EBITDA: ₹169 Cr
• Highest-ever quarterly EBITDA
• Sales volume: 8.7 million cases
• Imperial Blue integration ~90% complete
The interesting part for me is what happens from here.
Imperial Blue has given Tilaknagar much bigger scale.
If they can grow volumes, improve margins, reduce debt and get the benefits of operating leverage, earnings can grow significantly from here.
Management is targeting 16–18% EBITDA margin by FY29.
I am not looking at Tilaknagar for the next few quarters.
I am looking at it as a 3–5 year potential multibagger.
There will be ups and downs during the integration, but if the business executes well, I think the earnings growth can be much bigger than what we see today.
For me, the thesis is simple:
More scale + premiumisation + volume growth + margin expansion + debt reduction = potential multibagger.
CMP today: ~₹531.
Let's see where the business and the stock stand after 3–5 years.
Follow me only if you are interested in finding potential multibaggers and investing in good businesses for the long term.
#Tilaknagar #TI #Stocks #Investing #Multibagger
At current levels, Paradeep Phosphates appears suitable for staged accumulation for a 3–5 year investor. Q1 FY27 results were strong: revenue from operations rose 36% YoY to ₹6,124 Cr, EBITDA increased 24% to about ₹764 Cr, and PAT rose 24% to ₹393 Cr. Sales volume also increased 4% to 9.85 LMT. The company is progressing with its phosphoric-acid expansion and has approved a ₹250 Cr Aluminium Fluoride plant, providing additional long-term growth avenues. However, margins and fertilizer-cycle conditions should be monitored, so a staggered approach is preferable to an all-in investment.